TK needs to convert the various “advanced discussions contacts” into revenue paying clients. Everything else is just drivel at the moment. I cannot believe this current management hasn’t been able to convert Dx into anything meaningful other than Medgate and Alodokter. If, and i’m not convinced it will happen, they get FDA approval for Dx then all is forgiven. NO vote first.
RAP Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
